In this article
Carrageenan is a thickener made from red seaweed, and it is in a surprising amount of the dairy aisle: chocolate milk, cream, yoghurt, ice cream, and most plant-based milks, where it stops the drink separating and gives it body. It has been used for decades, it is permitted by every major food regulator, and the world's food-safety experts have repeatedly declined to call it dangerous. Yet it is also one of the most argued-about additives in food — because a long line of animal and laboratory studies links it to inflammation of the gut, because the only human trials ever run are three tiny ones that all point the same worrying way, and because Europe's own food safety authority set its intake limit as temporary in 2018, then estimated that toddlers who are loyal to high-carrageenan brands could exceed that limit tenfold. The debate is not really about whether carrageenan is a poison. It is about whether a substance that inflames the gut in animals and in a dish, at doses far above what people eat, does anything at all at the doses in a glass of chocolate milk — and whether the three small human trials are the first real signal or a false alarm from researchers who already believed the answer. This article lays out both sides with their numbers, so you can decide for yourself.
What carrageenan is
Carrageenan is a family of linear sulfated polysaccharides — long chains of sugar molecules carrying sulfate groups — extracted from red seaweed of the class Rhodophyceae. The US Food and Drug Administration's definition, in 21 CFR 172.620, describes it as "the refined hydrocolloid prepared by aqueous extraction" from members of the families Gigartinaceae and Solieriaceae, including Chondrus crispus and Eucheuma cottonii. Its sulfate content runs from 20 to 40 percent on a dry-weight basis, and its Chemical Abstracts Service number is 9000-07-1.
There are three commercial types, differing in the number of sulfate groups on each disaccharide unit. Kappa carries one and forms strong, rigid gels with potassium salts. Iota carries two and forms soft, elastic gels with calcium salts. Lambda carries three, forms no gel at all, and is used purely as a thickener.
The two E numbers are not the same product. E407 is refined carrageenan, from which the cellulose of the original seaweed has been removed by filtration. E407a is processed Eucheuma seaweed, in which the cellulose is retained. Food-grade carrageenan is a large molecule, with a weight-average molecular weight of 200 to 800 kilodaltons — while the degraded form at the centre of the debate, poligeenan, is far smaller, at 10 to 20 kilodaltons. Poligeenan is not authorised as a food additive in the EU or the US, is not used in any food application, and is classified by the International Agency for Research on Cancer as Group 2B, possibly carcinogenic to humans. Food-grade carrageenan itself has no such classification.
Why it is used
Carrageenan does three jobs at once, which is why manufacturers reach for it. The FDA authorises it as an emulsifier, stabiliser and thickener, "in the amount necessary" for those functions — there is no numeric cap in the US rule, only the requirement that no more be used than the job needs.
In practice, the job is texture and stability. In chocolate milk and plant-based milks it keeps cocoa and calcium from settling and stops the drink separating in the fridge. In yoghurt, cream and ice cream it gives body and a smooth mouthfeel, and in ice cream it helps control ice-crystal growth. In processed meats it binds water and holds the product together. In dressings, sauces and desserts it thickens without the starchy taste a flour thickener would bring, and it works at very low concentrations. Trade sources describe it as valued above other thickeners for the way it interacts with milk proteins, which is why it is hardest to replace in dairy and chocolate milk.
Where you will find it
- Chocolate milk and flavoured milks — the signature use: it keeps cocoa suspended and stops the milk separating
- Plant-based milks — almond, soy, oat and coconut milks, where it replaces the body dairy fat would provide
- Cream, yoghurt and cultured dairy — where it thickens and stabilises texture, particularly in low-fat products
- Ice cream and frozen desserts — where it controls texture and ice-crystal formation, and in dessert mixes, puddings and jams and jellies
- Processed meats — deli meats, sausages and canned meats, where it binds water and holds the product together
- Dressings, sauces and baked goods — where it thickens and stabilises emulsions, and in confections and cake mixes
- Infant formula — used as a stabiliser in the US; not authorised in infant formula in the EU
No authoritative source in the research for this article gave a verified range of typical use levels in food generally, so this article does not quote one — which is exactly why the exposure estimates in the regulators section disagree so widely.
Related: Added Sugars: The Sweetener Hiding in Plain Sight — and Why the Numbers Disagree — the other half of the processed-food label.
The concern: gut inflammation, and the degraded-carrageenan question
The concern starts with a review published in 2001 that has driven the argument ever since. Joanne Tobacman, a physician and researcher at the University of Illinois, reviewed 45 published animal studies in Environmental Health Perspectives and concluded that exposure to both undegraded and degraded carrageenan "was associated with the occurrence of intestinal ulcerations and neoplasms". Her central claims were that food-grade carrageenan is contaminated by degraded carrageenan, and that the stomach's acid could produce degraded carrageenan from it.
The laboratory mechanism work gives that claim a biological pathway. In cell-culture studies from Tobacman's group, carrageenan induced production of interleukin-8, an inflammatory signalling molecule, in normal human colonic epithelial cells — Bhattacharyya and colleagues in 2008 showed it working through the TLR4 receptor, via Bcl10 and the NF-κB pathway. These are in-vitro studies — carrageenan applied directly to cells in a dish, not dietary exposure — and that dose-and-route gap is the core criticism of them.
The animal studies are dramatic, and the doses are the problem. A 2024 review in Frontiers in Nutrition summarised the animal literature as consistently reporting that carrageenan induces features typical of inflammatory bowel disease. The examples are stark: degraded carrageenan in guinea pigs' drinking water produced ulcerations in the large intestine of all the animals within 30 days, and 5 percent degraded carrageenan in drinking water caused 15 to 25 percent body-weight loss and occult blood in all animals after 30 days. Both must be read with the same sentence attached: 5 percent in drinking water is far above any dietary use, and these are degraded-carrageenan studies, not food-grade ones. The cancer question turns on the same distinction: food-grade carrageenan is not classified as a carcinogen by any agency. What is classified is poligeenan, in Group 2B — and the sources disagree about the year of that evaluation, so this article does not state one.
What regulators say
The United States permits carrageenan without a numeric cap and has refused to remove it. The FDA's rule, 21 CFR 172.620, allows its use as an emulsifier, stabiliser or thickener "in the amount necessary". In June 2008 Tobacman petitioned the FDA to revoke that rule; the FDA denied the petition on 11 June 2012 (docket FDA-2008-P-0347), as reported in trade press and cited in Weiner's 2014 review. No FDA re-assessment in 2025 or 2026 was found, and no US state ban on carrageenan in food was found either.
EFSA's 2018 re-evaluation (EFSA Journal 2018;16(4):5238, adopted 14 March 2018) is the last full safety opinion. The authority concluded that carrageenan was not absorbed intact, found no adverse effects in chronic rat studies up to 7,500 milligrams per kilogram of body weight per day, and no concern for carcinogenicity or genotoxicity. But it made the existing group acceptable daily intake of 75 milligrams per kilogram of body weight per day temporary, "while the database should be improved within 5 years after publication of this opinion" — and no EFSA follow-up has been published since. The temporary status therefore stands, eight years on, with its five-year deadline passed.
The exposure finding is what makes the temporary limit matter. In a refined brand-loyal scenario — assuming a shopper always buys the highest-carrageenan brand in every category — EFSA estimated exposure of up to 758.6 milligrams per kilogram of body weight per day for toddlers, exceeding the temporary intake by up to approximately tenfold at the 95th percentile. EFSA said the exposure "may be overestimated" but that "the extent of the exceedance of the ADI (10-fold) may be a safety concern". Set against that, Weiner's 2014 review estimated human dietary intake at 18 to 40 milligrams per kilogram per day. The gap is a genuine disagreement about method.
The FAO/WHO Joint Expert Committee on Food Additives (JECFA) takes the most permissive view: an intake of "not specified", its least restrictive category, allocated in 1984 and reaffirmed in 2002. "Not specified" is not the same as "unlimited", and it is not the same as EFSA's numeric 75. Infant formula is where the regulators openly split: JECFA concluded in June 2014 that carrageenan in infant formula at up to 1,000 milligrams per litre is "not of concern", reversing its 2007 caution, largely on a 2015 piglet feeding study that found no adverse effects at up to 2,250 parts per million over 28 days. The study was conducted and funded by FMC Corporation and the International Formula Council, both industry bodies. The European Union takes the opposite position and does not authorise carrageenan in infant formulae or in processed cereal-based foods at all.
Commission Regulation (EU) 2026/196, adopted 28 January 2026 and applying from 18 August 2026, caps E407 at 300 milligrams per kilogram in milk-based drinks for young children, with a combined-use footnote so the maxima cannot be stacked. It does not change the intake limit or re-evaluate carrageenan's safety. On organic food, the US National Organic Standards Board voted in late 2026 to remove carrageenan from the organic list — the second such vote, after a 2016 vote (10 to 3, with one abstention) on the grounds that alternatives exist, not on safety, which the Department of Agriculture overruled in April 2018. The 2026 vote is a recommendation only, so carrageenan remains allowed in US organic food today.
The debate
The case for treating carrageenan as a gut risk
The case starts with a mechanism. Carrageenan switches on inflammatory signalling in human gut cells through the TLR4 receptor and the NF-κB pathway, and a 2001 review of 45 animal studies linked it to intestinal ulceration and tumours — and the only human evidence ever collected points the same way. In a randomised trial of people with ulcerative colitis in remission, 3 of the patients given carrageenan relapsed against none on placebo, in a trial of just 12 completers (p=0.046). In a 12-week pilot trial in 13 people with prediabetes, the carrageenan-free group saw glycated haemoglobin fall (p=0.006) and insulin resistance fall (p=0.026), while the carrageenan group saw no significant changes. And in a 2024 crossover trial in 20 healthy young men, independent of Tobacman's group, 500 milligrams a day — roughly two to three times a typical US intake — increased small-intestine permeability and reduced insulin effectiveness in the heavier participants. Add the regulatory loose end — Europe's intake limit still temporary eight years on — and the precautionary position writes itself.
The case for treating carrageenan as safe at food levels
The case starts with dose and route. Food-grade carrageenan is a large molecule of 200 to 800 kilodaltons that is excreted quantitatively in the faeces, is not significantly degraded by stomach acid or gut microflora, and is not significantly absorbed — the conclusion of Weiner's 2014 critical review, which found no intestinal ulceration at doses up to 5 percent of the diet, and animal intakes at least 1,000 milligrams per kilogram per day against an estimated 18 to 40 in the human diet. The cell-culture findings that anchor the critics' case could not be reproduced: McKim and colleagues spent two years trying to replicate them and found that intestinal cells did not absorb carrageenan, which was not cytotoxic and did not induce oxidative stress or inflammation — a study commissioned by the International Food Additives Council, an industry body. The human trials the critics cite are tiny and preliminary: 12, 13 and 20 people, short durations, marginal p-values, and the 2024 trial's primary endpoint, insulin sensitivity, was not significantly changed overall. The most current synthesis, a 2026 narrative review, puts it plainly: non-oral, high-dose, degraded-product and in-vitro findings "cannot be directly extrapolated to human dietary exposure".
The position this site takes follows the size of the evidence, not either slogan. The strongest case for caution is for people with ulcerative colitis or prediabetes — the two groups where the small human trials actually found something — and for parents choosing formula, where the world's regulators openly disagree. The weakest case is for alarm about an occasional ice cream: the evidence for harm at ordinary intakes is animal evidence at enormous doses and with degraded material. What should worry a careful reader most is the state of the evidence itself: three human trials with 45 people between them, a temporary intake limit with no published resolution eight years on, and exposure estimates that disagree tenfold. That is not a settled science. It is an open question.
Who should avoid it
- People with ulcerative colitis — the only randomised trial in the condition found earlier relapse on carrageenan, 3 relapses against none on placebo in 12 completers
- People with prediabetes — the 13-person pilot trial found improved glucose tolerance on a carrageenan-free diet, and the 20-person crossover trial found reduced insulin effectiveness in heavier participants
- Parents choosing infant formula — the FAO/WHO committee says up to 1,000 milligrams per litre is not of concern, while the EU does not authorise carrageenan in infant formula at all
- People who drink a lot of plant-based milk or chocolate milk every day — these are the products where carrageenan is most concentrated
- People with a sensitive gut who are already experimenting with their diet — there is no established test for carrageenan sensitivity, but it is one of the easier suspected triggers to remove
- People who prefer to minimise additives as a principle — carrageenan is permitted in US organic food today, but the organic standards board has now twice voted to remove it
How to spot carrageenan on a label
Carrageenan is one of the easier ingredients in this guide to spot, because it has a short name and a memorable number: "carrageenan", E407, E407a, or "processed Eucheuma seaweed". In Australia it may appear as thickener (407). It usually sits in the middle of the ingredients list, since it is used in small amounts and lists are ordered by weight.
- Carrageenan / E407 — refined carrageenan, the common form; if either appears, the product contains it
- E407a / processed Eucheuma seaweed — the semi-refined form, with the seaweed's cellulose retained; the same debate applies to it
- Thickener (407) — the Australian labelling format; the number is the E number without the E
- Check the products that carry it most — chocolate milk, plant-based milks, cream, yoghurt and ice cream first
- Check the same brand twice — a brand can use carrageenan in one product and a different thickener in another
- What "carrageenan-free" usually means — products marketed without it generally use gellan gum, guar gum, xanthan gum or locust bean gum instead
Alternatives: what replaces it
The replacements for carrageenan are the other hydrocolloid thickeners, and the four you will see most often are gellan gum, guar gum, xanthan gum and locust bean gum. They are the same gums named alongside carrageenan in the EU's 2026 combined-use footnote, and they were the explicit basis for the organic standards board's 2016 vote to delist carrageenan — the board's reasoning was that alternatives exist, not that carrageenan was unsafe. What follows is general trade knowledge rather than a researched comparison: no peer-reviewed head-to-head comparison of these gums was found in the research for this article.
Each of the four does a slightly different job. Gellan gum is the closest match in plant-based milks. Guar gum and locust bean gum are seed-derived thickeners often used together. Xanthan gum, made by bacterial fermentation, is the most versatile and the one most often used in gluten-free baking and dressings. The simplest alternative of all needs no label reading: products that list no thickener at all — plain milk, plain yoghurt, cream with a single ingredient — do not need carrageenan, because there is nothing in them that needs stabilising.
Frequently asked questions
What is carrageenan?
Carrageenan is a family of natural polysaccharides extracted from red seaweed, used as a thickener, stabiliser and emulsifier in food. On labels it appears as carrageenan, E407 (refined carrageenan) or E407a (processed Eucheuma seaweed). The three commercial types are kappa, iota and lambda, which gel and thicken differently. It is not the same thing as poligeenan, a degraded form made by harsh acid treatment that is not authorised as a food additive.
Is carrageenan safe to eat?
Regulators say yes at the amounts people typically eat, with a caveat. The US FDA permits carrageenan, the FAO/WHO expert committee gives it its least restrictive intake category, and Europe's food safety authority found no concern for genotoxicity or carcinogenicity — but it made its intake limit temporary in 2018 and its own exposure estimates exceed that limit by up to tenfold for toddlers. The honest answer is that the regulatory verdict is permissive, not unanimous, and the intake limit is formally unresolved eight years on.
Does carrageenan cause gut inflammation?
In animals and in cell culture, there is real evidence that it can: a 2001 review of 45 animal studies linked carrageenan to intestinal ulceration, and laboratory work shows it can switch on inflammatory signalling in gut cells. In people, the evidence is much thinner — three small randomised trials with 12 to 20 participants each found signals for earlier ulcerative-colitis relapse, worse blood-sugar control and increased gut permeability, but all three were small, short and preliminary. No large human trial has settled the question either way.
Is carrageenan in infant formula safe?
The experts disagree, which is itself the answer. The FAO/WHO expert committee concluded in 2014 that carrageenan in infant formula at up to 1,000 milligrams per litre is not of concern, reversing its earlier caution, largely on the basis of a piglet feeding study. The European Union takes the opposite position and does not authorise carrageenan in infant formula at all. If you are choosing formula, your paediatrician's advice matters more than either position on its own.
Is carrageenan allowed in organic food?
For now, yes in the United States. The National Organic Standards Board voted to remove carrageenan from the organic list in 2016, on the grounds that alternatives exist rather than on safety, and the US Department of Agriculture overruled that vote in 2018. The board voted to delist it again in late 2026, but that is a recommendation only — the department has not begun the rulemaking that would actually remove it, so carrageenan remains allowed in US organic food today.
How do I avoid carrageenan?
Look for carrageenan, E407, E407a or processed Eucheuma seaweed on the ingredients list, most often on chocolate milk, plant-based milks, cream, yoghurt, ice cream and desserts. In Australia it may appear as thickener (407). The simplest way to cut it out is to choose products that list no thickener at all, or products thickened with gellan gum, guar gum, xanthan gum or locust bean gum instead — and to check the label every time, since the same brand can use different thickeners in different products.
Checked against EFSA's 2018 re-evaluation of carrageenan (E407/E407a), the FAO/WHO expert committee's infant-formula assessment, the US Code of Federal Regulations 21 CFR 172.620, and Commission Regulation (EU) 2026/196 · Last updated 2026-11-07 · How we assess ingredients
Sources (19)
- US Code of Federal Regulations, Title 21, Part 172 — §172.620 (Carrageenan), §§172.623/172.626: the FDA's definition of carrageenan as the refined hydrocolloid from red seaweed of the families Gigartinaceae and Solieriaceae, sulfate content 20 to 40 percent on a dry-weight basis, permitted as an emulsifier, stabiliser or thickener "in the amount necessary"; related sections cover carrageenan with polysorbate 80 and the salts of carrageenan
- EFSA Panel on Food Additives and Nutrient Sources (ANS) — Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives. EFSA Journal 2018;16(4):5238: the group intake of 75 mg/kg body weight per day made temporary pending better data within 5 years; subchronic rat no-effect level 3,400–3,900 mg/kg per day and no adverse effects in chronic studies up to 7,500 mg/kg per day; no concern for carcinogenicity or genotoxicity; carrageenan not absorbed intact; weight-average molecular weight 200–800 kDa; refined brand-loyal exposure up to 758.6 mg/kg per day for toddlers, exceeding the temporary intake by up to tenfold at the 95th percentile; carrageenan not authorised in infant formulae or processed cereal-based foods; poligeenan (10–20 kDa) not authorised as a food additive and not used in any food application
- Food and Agriculture Organization of the United Nations — "7. Carrageenan" (Guide to the seaweed industry): the three commercial types — kappa (strong rigid gels with potassium), iota (elastic gels with calcium, freeze/thaw stable) and lambda (no gel, thickener only) — with the source species for each, and the distinction between refined carrageenan and processed Eucheuma seaweed, which retains the cellulose of the original seaweed
- Joint FAO/WHO Expert Committee on Food Additives (JECFA) — WHO Food Additives Series 42 (51st meeting, 1999) and Series 48 (57th meeting, 2001): the history of carrageenan's intake limit, from 0–75 mg/kg body weight per day (1974) to "not specified" (1984), the temporary group intake imposed in 1999 over colon-cancer promotion data in rats, and the withdrawal of the temporary status and allocation of the full group intake "not specified" in 2001
- Weiner ML (2014). Food additive carrageenan: Part II: A critical review of carrageenan in vivo safety studies. Critical Reviews in Toxicology 44(3):244–269: ingested carrageenan is excreted quantitatively in the faeces, is not significantly degraded by stomach acid or gut microflora, and is not significantly absorbed or metabolised; food-grade carrageenan does not produce intestinal ulceration at doses up to 5% of the diet; animal no-effect doses of at least 1,000 mg/kg per day against an estimated human dietary intake of 18–40 mg/kg per day; also the source for the FDA's 2012 denial of the petition to revoke 21 CFR 172.620
- FoodAdditives.net — "What Is Carrageenan (E407) In Food? Types, Uses, Safety, Side Effects" (secondary/trade source): the foods carrageenan is used in — dairy products, plant-based milks, desserts, processed meats, baked goods, dressings, frozen desserts, confections and puddings — and its value in the way it interacts with milk proteins
- Tobacman JK (2001). Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environmental Health Perspectives 109(10):983–994: a review of 45 published animal studies concluding that exposure to undegraded as well as degraded carrageenan was associated with intestinal ulcerations and neoplasms, and that the widespread use of carrageenan in the Western diet should be reconsidered; the claim that degraded carrageenan could be produced from undegraded carrageenan under conditions similar to normal digestion
- Bhattacharyya S et al. (2017). A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging 4(2):181–192: randomised, double-blind, placebo-controlled trial in adults with ulcerative colitis in remission; 12 patients completed the study, 3 on carrageenan relapsed against 0 on placebo (p=0.046, log-rank); interleukin-6 rose in the carrageenan group (p=0.02) and faecal calprotectin rose (p=0.06, not significant)
- Feferman L et al. (2020). Carrageenan-free diet shows improved glucose tolerance and insulin signaling in prediabetes: a randomized, pilot clinical trial. Journal of Diabetes Research 2020:8267980: 12-week randomised pilot trial in 13 people with prediabetes; the no-carrageenan group (n=8) saw glycated haemoglobin fall (p=0.006), HOMA-IR fall (p=0.026) and C-peptide rise (p=0.029), with the Matsuda Index rising from 2.1±0.7 to 4.8±2.3 (p=0.052); the carrageenan group (n=5) saw no significant changes; the authors call for larger studies
- Wagner R et al. (2024). Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial. BMC Medicine 22:558 (press summary via the German Center for Diabetes Research): 20 healthy men, mean age 27.4 and mean BMI 24.5, given 250 mg of carrageenan twice daily for two 2-week periods with a 21–35 day washout; the primary endpoint, insulin sensitivity, was not significantly changed overall; small-intestinal permeability increased, most likely through inflammation of the gut, and insulin effectiveness fell in participants with higher body weight; the dose was roughly two to three times the daily dose consumed in the USA
- Environmental Working Group (EWG) — Food Scores, ingredient: Carrageenan (advocacy organisation, not a regulator): EWG's headline rating is "lower concern in food"; its concern entries are quotations from the FAO/WHO expert committee — limited evidence of colon-cancer promotion in laboratory animals at high doses, and gastrointestinal inflammation in laboratory animals at high doses — not EWG's own studies
- Commission Regulation (EU) 2026/196 of 28 January 2026 (applies from 18 August 2026): amends the EU's authorised-uses list so that E407 is capped at 300 mg/kg in milk-based drinks for young children, with a combined-use footnote providing that the maxima for the listed gums cannot be stacked; the regulation does not change the acceptable daily intake and does not re-evaluate carrageenan's safety
- National Organic Standards Board, October 2026 vote to delist carrageenan from organic (advocacy reporting, via the Cornucopia Institute; see also OrganicEye's meeting recap): the board voted to remove carrageenan as an approved non-organic material for use as a food ingredient — a recommendation only, with US Department of Agriculture rulemaking still to come. For the history: the board previously voted to delist in 2016 (10–3, 1 abstention) on essentiality grounds, and the department overruled that vote in April 2018, renewing carrageenan on the National List until 29 May 2023
- FDA denial of the Tobacman citizen petition (11 June 2012, Docket FDA-2008-P-0347) — reported via trade press and cited in Weiner (2014): the FDA denied the petition to revoke 21 CFR 172.620, concluding that carrageenan consumed in food is safe and is not a carcinogen, tumour promoter or ulcer-causing substance in animal studies; the denial letter itself was not available as a primary text for this article
- Weiner ML et al. (2015). An infant formula toxicity and toxicokinetic feeding study on carrageenan in preweaning piglets. Food and Chemical Toxicology 77:120–131: preweaning piglets fed carrageenan at 0, 300, 1,000 and 2,250 parts per million (about 51, 192 and 430 mg/kg body weight per day) for 28 days, with no treatment-related adverse effects at any concentration; the study was conducted and funded by FMC Corporation and the International Formula Council. The FAO/WHO expert committee's 2014 conclusion — carrageenan in infant formula at up to 1,000 mg/L is "not of concern" — rests on this study
- "Carrageenan: Food Additive or Health Concern? A Comprehensive Review" (2026): the most recent synthesis, concluding that the evidence remains contradictory, that regulators generally consider carrageenan safe while concerns remain about infant formula and long-term exposure, and that carrageenan "cannot be uniformly classified as beneficial or harmful" because its biological effects are context-specific
- McKim JM et al. (2016). Effects of carrageenan on cell permeability, cytotoxicity, and cytokine gene expression in human intestinal and hepatic cell lines. Food and Chemical Toxicology (July 2016) — reported via trade summary: after two years trying to replicate the Tobacman group's in-vitro findings, the authors found intestinal cells did not absorb carrageenan, which was not cytotoxic and did not induce oxidative stress or inflammation, and were unable to reproduce any of the previously reported in-vitro findings; the study was commissioned by the International Food Additives Council, an industry body
- Weiner ML (2016). Parameters and pitfalls to consider in the conduct of food additive research, carrageenan as a case study. Food and Chemical Toxicology 87:31–44; addendum with McKim and Blakemore (2017) 107:208–214: doses of high-molecular-weight non-caloric additives should not exceed 5% of the total solid diet, and the strong binding of carrageenan to protein in rodent chow or infant formula results in no gastrointestinal exposure to free carrageenan; degraded carrageenan and poligeenan are not food additives and have completely different physical, chemical and toxicological properties from carrageenan. See also Weiner and McKim (2019), Food & Function 10:1763–1766, a reply on the digestive fate and safety of carrageenan
- "Mechanisms of Carrageenan-Induced Immune Inflammation and Thrombosis: A Narrative Review" (Foods, 19 October 2026; 15(20):3727): route determines outcomes — intravenous, intraperitoneal and oral carrageenan behave differently — and the findings from non-oral, high-dose, degraded-product and in-vitro studies "cannot be directly extrapolated to human dietary exposure"; under conditions of an intact barrier and normal dietary exposure, the evidence does not indicate a consistent pro-inflammatory or pro-thrombotic risk of food-grade carrageenan, while not excluding all potential effects
